|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.560 USD | -4.50% |
|
-9.84% | +30.71% |
| 06-29 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 227M 198M 183M 169M 319M 21.79B 325M 2.19B 857M 10.67B 852M 833M 36.74B | P/E 2026 * |
-2.4x | P/E 2027 * | -3.23x |
|---|---|---|---|---|---|
| Enterprise Value | 480M 419M 388M 358M 674M 46.09B 687M 4.62B 1.81B 22.57B 1.8B 1.76B 77.71B | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 1.46x |
| Free-Float |
95.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | -4.40% | ||
| 1 week | -9.84% | ||
| Current month | -1.54% | ||
| 1 month | -0.21% | ||
| 3 months | +12.38% | ||
| 6 months | +44.44% | ||
| Current year | +30.71% |
| 1 week | 9.52 |  | 10.76 |
| 1 month | 8.78 | | 10.86 |
| Current year | 5 | | 10.99 |
| 1 year | 3.65 | | 10.99 |
| 3 years | 3.51 | | 29.25 |
| 5 years | 3.51 | | 220.95 |
| 10 years | 3.51 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 03/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 03/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 62 | 01/01/2013 |
| Director/Board Member | 61 | 01/04/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 03/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-21 | Free | Director | 15,508 | 0.0688% | ||
| 05-21 | Free | Director | 15,508 | 0.0688% | ||
| 05-21 | Free | Director | 15,508 | 0.0688% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.50% | -9.84% | +126.89% | -58.08% | 227M | |
| +1.33% | +0.02% | +21.00% | -8.12% | 66.75B | |
| +1.29% | -5.31% | +37.96% | +193.79% | 50.65B | |
| +1.10% | +38.30% | +38.30% | +38.30% | 42.55B | |
| -0.98% | -1.79% | -49.61% | -53.35% | 41.15B | |
| +1.50% | -3.34% | +51.90% | -30.43% | 28.34B | |
| -0.53% | -9.19% | +112.22% | -45.33% | 26.76B | |
| -0.03% | -2.50% | +67.52% | +87.18% | 22.95B | |
| +7.77% | +11.30% | +18.35% | +199.08% | 20B | |
| -2.01% | +5.50% | +75.95% | +157.91% | 16.48B | |
| Average | +0.49% | -2.18% | +50.05% | +48.09% | 31.59B | |
| Weighted average by Cap. | +0.96% | -2.97% | +33.51% | +48.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 137M 120M 111M 102M 193M 13.18B 196M 1.32B 519M 6.45B 515M 504M 22.22B | 155M 136M 125M 116M 218M 14.92B 222M 1.5B 587M 7.3B 583M 570M 25.15B |
| Net income | -121M -106M -97.77M -90.33M -170M -11.62B -173M -1.17B -457M -5.69B -455M -445M -19.6B | -135M -118M -109M -100M -189M -12.92B -193M -1.3B -509M -6.33B -505M -494M -21.79B |
| Net Debt | 253M 221M 204M 189M 356M 24.3B 362M 2.44B 956M 11.9B 950M 929M 40.97B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | $9.585 | -4.25% | 97,970 |
| 14/07/26 | $10.01 | -0.40% | 481,544 |
| 13/07/26 | $10.05 | -2.80% | 431,397 |
| 10/07/26 | $10.34 | +1.37% | 320,246 |
| 09/07/26 | $10.20 | -4.40% | 281,109 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
